To slow progression of DN, blockade of the renin-angiotensin-aldosterone system (RAAS) via angiotensin II (Agt II) receptor antagonists or angiotensin converting enzyme (ACE) inhibitors is recommended (11, 12). Here, ACE is linked to liver dysplastic nodule.